0 Commentaires
0 Parts
1029 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
- Blogs
- Offres
- Emplois
- Connectez-vous pour aimer, partager et commenter!
- Europe and U.S. Lead Global Expansion in Plasmid DNA Manufacturing MarketThe global plasmid DNA manufacturing market, valued at USD 2.38 billion in 2024, is anticipated to expand at a CAGR of 21.7% from 2025 to 2034, with growth increasingly driven by segment-wise performance across scale, end-user applications, and technological platforms. Unlike traditional plasmid production for research, GMP-compliant manufacturing for clinical and commercial use requires...0 Commentaires 0 Parts 1065 Vue 0 Aperçu
- Plasmid DNA Manufacturing Market Segmentation Analysis by Application, End-Use, and RegionThe global plasmid DNA manufacturing market, valued at USD 2.38 billion in 2024, is anticipated to register a compound annual growth rate (CAGR) of 21.7% from 2025 to 2034, driven by the explosive demand for high-purity plasmid DNA (pDNA) as a foundational component in gene therapies, mRNA vaccines, and viral vector production. As the biopharmaceutical industry shifts toward advanced modalities...0 Commentaires 0 Parts 980 Vue 0 Aperçu
- Powering Gene Therapy: Growth in the Viral Vector and Plasmid DNA Manufacturing Market“According to a new report published by Introspective Market Research, titled, Viral Vector and Plasmid DNA Manufacturing Market by Vector Type, Workflow, Application, and End-User, The Global Viral Vector and Plasmid DNA Manufacturing Market Size Was Valued at USD 5.4 Billion in 2023 and is Projected to Reach USD 28.9 Billion by 2032, Growing at a CAGR of 20.9%.” Introduction /...0 Commentaires 0 Parts 508 Vue 0 Aperçu
- Segment-Wise Pricing, Performance, and Adoption Trends in the Global Plasmid DNA Manufacturing MarketThe global plasmid DNA manufacturing market, valued at USD 2.38 billion in 2024, is anticipated to expand at a CAGR of 21.7% from 2025 to 2034, with growth increasingly driven by segment-wise performance across scale, end-user applications, and technological platforms. Unlike traditional plasmid production for research, GMP-compliant manufacturing for clinical and commercial use requires...0 Commentaires 0 Parts 997 Vue 0 Aperçu